Close Menu
  • Wed, November 22, 2017

    Array Biopharma, Inc. [NASDAQ: ARRY]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Array Biopharma, Inc. Oklahoma City, OK (November 22, 2017) – On November 20, 2017, a securities class action lawsuit was filed in the United States District Court for the District of Colorado against Array Biopharma, Inc. (NASDAQ: ARRY). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of...

    Learn More
  • Wed, November 08, 2017

    General Electric Company [NYSE: GE]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against General Electric Company Oklahoma City, OK (November 8, 2017) – On November 1, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against General Electric Company (NYSE: GE). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a...

    Learn More
  • Wed, October 25, 2017

    Antares Pharma, Inc.

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Antares Pharma, Inc. Oklahoma City, OK (October 25, 2017) – On October 23, 2017, a securities class action lawsuit was filed in the United States District Court for the District of New Jersey against Antares Pharma, Inc. (NASDAQ: ATRS). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series...

    Learn More
  • Wed, October 18, 2017

    Navient Corporation [NASDAQ: NAVI]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Navient Corporation Oklahoma City, OK (October 18, 2017) – On October 16, 2017, a securities class action lawsuit was filed in the United States District Court for the District of New Jersey against Navient Corporation (NASDAQ: NAVI). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material...

    Learn More
  • Wed, October 11, 2017

    Tesla, Inc. [NASDAQ: TSLA]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Tesla, Inc. Oklahoma City, OK (October 11, 2017) – On October 10, 2017, a securities class action lawsuit was filed in the United States District Court for the Northern District of California against Tesla, Inc. (NASDAQ: TSLA). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material...

    Learn More
  • Wed, October 04, 2017

    Health Insurance Innovations, Inc. [NASDAQ: HIIQ]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Health Insurance Innovations, Inc. Oklahoma City, OK (October 4, 2017) – On September 11, 2017, a securities class action lawsuit was filed in the United States District Court for the Eastern District of New York against Health Insurance Innovations, Inc. (NASDAQ: HIIQ). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of...

    Learn More
  • Fri, September 29, 2017

    Avalanche Biotechnologies, Inc. - Settlement Notice

    To: All persons and/or entities who purchased common stock in Avalanche Biotechnologies, Inc. [AAVL] during the period between July 30, 2014 and June 15, and were damaged thereby; a settlement has been announced in the securities litigation known as In re: Avalanche Biotechnologies, Inc. Shareholder Litigation, CIV536488 (Superior Court of the State of Californioa, County of San Mateo) For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed...

    Learn More
  • Fri, September 29, 2017

    SCANA Corporation [NYSE: SCG]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against SCANA Corporation Oklahoma City, OK (September 29, 2017) – On September 27, 2017, a securities class action lawsuit was filed in the United States District Court for the District of South Carolina against SCANA Corporation (NYSE: SCG). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material...

    Learn More
  • Mon, May 15, 2017

    Akari Therapeutics, Plc [NASDAQ: AKTX]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Akari Therapeutics, Plc Oklahoma City, OK (May 15, 2017) – On May 12, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against Akari Therapeutics, Plc (NASDAQ: AKTX). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a...

    Learn More
  • Tue, May 09, 2017

    Vince Holding Corp. [NYSE: NVCE]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Vince Holding Corp. Oklahoma City, OK (May 9, 2017) – On May 5, 2017, a securities class action lawsuit was filed in the United States District Court for the Eastern District of New York against Vince Holding Corp. (NYSE: VNCE). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a...

    Learn More
  • Thu, May 04, 2017

    KBR, Inc. [NYSE: KBR]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against KBR, Inc. Oklahoma City, OK (May 4, 2017) – On May 3, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of Texas against KBR, Inc. (NYSE: KBR). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material...

    Learn More
  • Tue, April 18, 2017

    Lion Biotechnologies, Inc. [NASDAQ: LBIO]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Lion Biotechnologies, Inc. Oklahoma City, OK (April 18, 2017) – On April 14, 2017, a securities class action lawsuit was filed in the United States District Court for the Northern District of California against Lion Biotechnologies, Inc. (NASDAQ: LBIO). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series...

    Learn More
  • Mon, April 17, 2017

    U.S. Physical Therapy, Inc. [NYSE: USPH]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against U.S. Physical Therapy, Inc. Oklahoma City, OK (April 17, 2017) – On March 31, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against U.S. Physical Therapy, Inc. (NYSE: USPH). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of...

    Learn More
  • Wed, March 29, 2017

    U.S. Concrete, Inc. [NASDAQ: USCR]

    Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against U.S. Concrete, Inc. Oklahoma City, OK (March 29, 2017) – On March 28, 2017, a securities class action lawsuit was filed in the United States District Court for the Northern District of Texas against U.S. Concrete, Inc. (NASDAQ: USCR). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series...

    Learn More